SEC Form 4 · accession 0001562180-18-005115
G1 Therapeutics, Inc. · GTHX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James S. Hanson
Officer — General Counsel
Period of report
Dec 26, 2018
Accepted (ET)
Dec 27, 2018 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 26, 2018 | P | 1,000 | $18.25 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.